2394.8000 25.70 (1.08%)
NSE Jan 14, 2026 15:31 PM
Volume: 56,103
 

2394.80
1.08%
Karvy
Revenue growth lower than estimates: Revenues for the quarter at Rs 8821 mn were below our estimates of Rs 9469mn on account of lower traction.
GlaxoSmithKline Phar.. has an average target of 2750.00 from 2 brokers.
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended